Showing posts with label Life Technologies. Show all posts
Showing posts with label Life Technologies. Show all posts

Wednesday, 25 April 2012

Economic Development-Genetic Sequencing-Life Technologies-Drug Development-Manufacturing

Life Technologies expands manufacturing in Scotland

The use of genetic sequencing in drug development is expanding and Life Technologies ($LIFE) is lining up its pieces to get more of that market with a manufacturing plant expansion in Scotland.The company says that Scottish economic development agencies are providing some help so that it can invest $20 million in its operations in Inchinnan. The expansion will increase production of its GIBCO cell culture products.The company said it expects the site up and running next year and actually shipping products in 2014. It will serve markets in Europe, the Middle East and Africa. There are currently 500 employees working at its facility at Inchinnan.It didn't disclose the level of incentives provided by Scotland, but Life Technologies CEO Gregory Lucier said the company is "grateful for the support."Life Technologies seems to be reminding potential customers it is in the game after all of the attention has been focused on competitor Illumina ($ILMN) and its back-and-forth battle with Roche ($RHHBY). The Swiss company last week gave up its $6.7 billion, $51-per-share bid for Illumina after its board repeatedly threw up roadblocks to the hostile takeover attempt.- here's the PBR story
- check out Life Technologies' releaseRelated Article:
Roche's bid for Illumina may be kaput read more..

Monday, 19 March 2012

Life Technologies Corporation-Energieforschung Geeignet-Bioscience Industry-Global Provider

Life Technologies Launches GeneArt® Precision TALs

CARLSBAD, Calif., March 19, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ:LIFE) today announced the launch of GeneArt® Precision TALs, generally referred to as TAL effector proteins (TALE), which will allow researchers the ability to edit genomes and control gene.. read more..


Life Technologies führt Präzisions-TAL-Effektoren GeneArt® ein

CARLSBAD, Kalifornien, March 19, 2012 /PRNewswire/ --- Lifes TAL-Effektorproteine ermöglichen eine präzise Bearbeitung von Genomen und sind zur Anwendung im Gesundheitswesen, der Landwirtschaft und der Energieforschung geeignetLife Technologies Corporation (NASDAQ:LIFE)... read more..


BioStorage Technologies to Host Live Webinar on Optimizing the Value of Sample Assets

INDIANAPOLIS, March 19, 2012 /PRNewswire/ -- BioStorage Technologies, a global provider of comprehensive sample management solutions, biomaterial storage and cold chain logistics for the bioscience industry, announced today that it will host a live, complimentary webinar titled,... read more..